key: cord-0903923-buy26ng5
authors: Markovič, Rene; Šterk, Marko; Marhl, Marko; Perc, Matjaž; Gosak, Marko
title: Socio-demographic and health factors drive the epidemic progression and should guide vaccination strategies for best COVID-19 containment
date: 2021-06-08
journal: Results Phys
DOI: 10.1016/j.rinp.2021.104433
sha: f92fdce6e5687f0de38630c61ac805dfa782c10d
doc_id: 903923
cord_uid: buy26ng5

We propose and study an epidemiological model on a social network that takes into account heterogeneity of the population and different vaccination strategies. In particular, we study how the COVID-19 epidemics evolves and how it is contained by different vaccination scenarios by taking into account data showing that older people, as well as individuals with comorbidities and poor metabolic health, and people coming from economically depressed areas with lower quality of life in general, are more likely to develop severe COVID-19 symptoms, and quicker loss of immunity and are therefore more prone to reinfection. Our results reveal that the structure and the spatial arrangement of subpopulations are important epidemiological determinants. In a healthier society the disease spreads more rapidly but the consequences are less disastrous as in a society with more prevalent chronic comorbidities. If individuals with poor health are segregated within one community, the epidemic outcome is less favorable. Moreover, we show that, contrary to currently widely adopted vaccination policies, prioritizing elderly and other higher-risk groups is beneficial only if the supply of vaccine is high. If, however, the vaccination availability is limited, and if the demographic distribution across the social network is homogeneous, better epidemic outcomes are achieved if healthy people are vaccinated first. Only when higher-risk groups are segregated, like in elderly homes, their prioritization will lead to lower COVID-19 related deaths. Accordingly, young and healthy individuals should view vaccine uptake as not only protecting them, but perhaps even more so protecting the more vulnerable socio-demographic groups.

Currently we are experiencing a global COVID-19 epidemic affecting almost all countries in the world.

The high infection rate and relatively long hospitalization of risk groups presents a great concern for governments, and a challenge for researchers trying to prevent an economic, social and political crisis [1, 2] . This has stimulated an unprecedented interest in epidemiological models, especially predicting the outcomes of scenarios considering counter-and prevention measures, in particular the forthcoming vaccination. Complex systems and network science approaches, along with technological advances and data availability, are becoming instrumental for the design of effective containment strategies [3] [4] [5] [6] [7] . Numerous recent works are devoted to fitting of the available data [8, 9] , inferring the key epidemiological processes [10] [11] [12] , identifying the control knobs for nonpharmaceutical interventions [13, 14] , aiding decisions on emergency management [15, 16] , checking the effectiveness and importance of lockdowns [17] and making predictions about the further epidemic progression [18] [19] [20] , with the aim to support the decision-making process amid the crisis.

For COVID-19 it is widely believed that the society will not be able to return to normal pre-pandemic life until a global vaccination program is successfully implemented [21] . Finding efficient vaccine administration strategies is crucial, not only because the pandemic has generated simultaneous demand all around the globe, which rises technical as well as moral considerations in decision making, but also due to anti-vaccination movements and conspiracy theories that have the potential to reduce vaccine uptake [22, 23] . Moreover, the epidemic progression depends largely on the heterogeneity of the population [24, 25] . Firstly, different age and social groups can have different frequencies of interactions, which has been shown to substantially affect epidemiological parameters of the new coronavirus disease [26, 27] . Secondly, infected individuals express highly heterogeneous clinical and immunological manifestations of COVID-19 and high variability is also expected in responses to vaccination [28] . For these reasons, assessing the pandemic evolution and the corresponding ongoing immunization processes should also take notice of the broader socioeconomic, cultural as well as immunological and other biological factors.

The nature of protective immune responses is one of the main questions in COVID-19 research [21] .

Besides the age, it is not clear how different sub-populations respond to natural infection or vaccination. One of the biggest concerns nowadays is how metabolic disorders and other related diseases may hinder COVID-19 vaccine efficacy [29] . Previous studies for other viral diseases, e.g., influenza, have shown a reduced effectiveness of vaccinations in people with obesity [30, 31] . It has been shown that obese individuals 12 months after vaccination had a decreased CD8+ T cell activity and a more pronounced decline in influenza antibody titers [32] . For individuals with metabolic-related diseases, a shorter post-vaccination immunity has also been confirmed for hepatitis B and tetanus [33] . Therefore, different types of comorbidities affecting perturbations in the immune system are also likely to have implications for COVID-19 vaccination [31] .

In the last year, a significant number of different types of models have been designed to simulate and predict the trajectories of the COVID-19 pandemic and to explore how herd immunity will contain the pandemic once a sufficiently high proportion of the population acquires immunity [34, 35] . Mathematical models have been used to explore the possible epidemic progressions with regard to variations in immune responses following SARS-CoV-2 infection and vaccination [25, 36] and to evaluate and derive optimal prioritization strategies of vaccine administration [37] [38] [39] . It has been argued that models of COVID-19 transmission should aim to capture the complex interactions between individuals in the heterogeneous and geographically dispersed populations. The reason being that these factors, along with other behavioral interventions, importantly contribute to the dynamics of the disease [40, 41] . Moreover, considering that decision making will have to take place under uncertainty and imperfect information, and with only conditionally optimal outcomes, game theory and social network models could be a valuable repertoire to guide decisions pertaining to vaccination programs [42] . In studies of disease transmission in heterogeneous populations, where individual characteristics or characteristics of subgroups may play a decisive role, network models and agentbased modeling formulations have already proven beneficial [43] [44] [45] [46] [47] , including in simulations of vaccination [36, [48] [49] [50] . These models represent a clear departure from the homogeneity assumptions of the traditional well-mixed compartment models and have already been used in the context of COVID-19 epidemic. Specifically, it has been shown that utilizing accurate social network models can provide better insights into the spread of the new coronavirus disease [51] [52] [53] [54] , improve the forecast of the evolution of the epidemic [55, 56] and help to design efficient strategies to control COVID-19 outbreaks [57] .

In this work, we explore how heterogeneity in health status along with spatial distribution patterns within the population influences the progression of the epidemic. Subpopulations with different grades of comorbidities have different responses to virus infection and to vaccination. In subpopulations with a lower health status, it is expected that the probability for a severe form of the disease is higher and the immune periods are shorter, which might considerably affect the spread of COVID-19 in a network of interacting individuals. To address these issues, we utilize a stochastic multicompartment epidemic model and analyze how a variable transient immunity in a heterogeneous population affects the dynamics and outcome of the epidemic.

We have developed an agent-based computational model to simulate the spread of the new coronavirus disease and vaccination in a heterogeneous population. In the model we consider that individuals have diverse medical conditions by arranging them into three subgroups. We utilize a stochastic extended SEIRS formalism and explore how these aspects affect the progression and outcome of the COVID-19 epidemic. Our framework incorporates the epidemiological compartments characteristic for COVID-19 and in which individuals interact via a realistic social network scheme. The outline of the model is schematically presented in Fig. 1 , whereas a detailed description of individual segments of the model is given in continuation. Moreover, we have performed a detailed literature overview to estimate the implemented model parameters on published data, which are provided in the Supplementary text S1. . See main text and Tables S1 and S2 in the Supplementary text S1 for a detailed description of the compartments, residence times, transmission probabilities, and other parameters.

In our simulations, N individuals are initially distributed into three categories, characterizing the individual's health status. Fractions p RG1 , p RG2, and p RG3 of individuals are assigned to the categories risk group 1 (RG1), risk group 2 (RG2), and risk group 3 (RG3), respectively, so that p RG1 + p RG2 + p RG3 = 1 (see Fig. 1A ). In the subcategory RG1, we consider healthy Individuals with no underlying medical condition.

Individuals assigned to RG2 have moderate underlying medical conditions, whereas individuals assigned to RG3 have full-blown metabolic disorders and other related severe diseases. These risk groups are used to model COVID-19 progression specific to the corresponding underlying medical conditions. Individuals from RG2 and RG3 exhibit a higher risk of developing severe symptoms, they are more likely to get hospitalized and their immune periods are shorter. Their specific parameters in terms of transition probabilities between compartments, compartments specific residence durations, and length of immunity after vaccination and recovery from COVID-19 are given in Table S3 . It should be noted that in our model, we do not explicitly consider different age groups. However, the distribution of individuals within the categories can be regarded to reflect the population's age structure, but a lower health status can, in general, also be a consequence of the presence of disadvantaged socio-economic groups.

To simulate the human interaction patterns, we utilize the random geometric graphs in hyperbolic spaces. This network model produces interaction structures with genuine characteristics of social networks [58] [59] [60] . Networks embedded in hyperbolic spaces exhibit a small diameter, strong clustering, community structure, and a heterogeneous degree distribution and are therefore commonly used to simulate various social phenomena, including epidemics [61] [62] [63] . In our study, we utilized the geometric preferential attachment model, where each newly added node i is mapped into the hyperbolic disc with randomly assigned polar coordinates:

where, α is the internal growth parameter, R hd =1 is the radius of the hyperbolic disc, and u 1 and u 2 are independent random variables sampled from the uniform distribution on a unit interval. The new ith node connects with n=5 existing nodes with a probability that is proportional to the distance between the i-th and the j-th node:

where is the angular distance [58] . Notably, the polar coordinate r i reflects ∆ = -| -| -|| individuals' popularity, as the nodes at the disc's periphery exhibit fewer connections than the nodes that are close to the center. Moreover, nodes separated by a small angular distance correspond to individuals that can be regarded to live and operate in the same geographic region or belong to the same geo-political or socio-economic group [64] . We used parameters , , , = 0.15 hd = 1 < >= 10 and nodes, which yielded realistic social network architectures. = 10 5

In our study, we additionally investigate how the epidemic trajectories are affected by the spatial distribution of the risk groups within the population. We consider two extreme scenarios. In the first case, we homogeneously distribute the individuals from all 3 risk groups throughout the whole network. In the second case, we spatially segregate individuals belonging to RG1 from individuals belonging to RG2 and RG3, so that they are all in one district. The distributions of individuals with lower health status for both types of populations and how they are arranged within the social network model are visualized in Fig. 2 . 

Infection-disease spreading in a network is modeled with the extended SEIRS compartment model. In addition to the standard compartments susceptible (S), exposed (E), infected (I), and recovered (R), we incorporated the following compartments: presymptomatic (P), hospitalized (H), vaccinated (V), vaccine-induced immunity (I m ) and deceased (D). The compartment labeled as infected was divided into two separate compartments, namely the asymptomatically infected (I A ) and symptomatically infected (I S ), as schematically presented in Fig. 1C . It should be noted that for practical reasons only nodes which will certainly become infected enter the state transient E, whereas nodes who were in contact with an infectious node and did not become infected, remain formally in state S. In the simulation, each node of the network can be in one of these exclusive states. Nodes interact in accordance with the underlying network structure and once a susceptible node interacts with an infected node, it is transferred to state E with a given probability. Afterwards, the state of the nodes changes with time in accordance with the model assumptions, which are explained in more detail in continuation. Description of the transition probabilities and residence times, separately for different population groups, along with the corresponding references, is provided in the Supplementary text S1.

It should be noted that the data from the literature that we used to calibrate our model exhibits large variations. As pointed out by Català et al. [65] , any analysis based on diagnosed cases is biased by diagnosis protocols. Moreover, several other factors contribute to the observed variation in country specific COVID-19 statistics, like for example the pool of asymptomatic cases and the health system structure, which should be kept in mind when designing COVID-19 epidemic models.

Finally, we incorporate restrictions q, which simulate the effect of non-pharmaceutical interventions to control virus spreading and affect infection rates as follows:

where , and are the probabilities of a susceptible individual becoming infected from a 

individuals is given a larger weight (see Table S3 ). We considered two intensities of prevention measurements in our simulations: one strict (Q50) and the other more permissive (Q25).

We perform Monte Carlo simulations to simulate the spreading of the COVID-19 through a complex network of interacting individuals, some of which have different grades of comorbidities. In accordance with the underlying health status category, we assign every node a specific set of parameters that govern the disease's progression. We initially select 0.1% of nodes at random in all our simulations and designate them as infected/presymptomatic (P), whereas all other nodes are designated as susceptible (S). In each full Monte Carlo step (MCS), the following elementary step is repeated N times, with N being the size of the population. A node i is selected uniformly at random from the whole network, and if the selected node i is in state S, we randomly choose one of its neighbors j. If node j is in an infectious state (compartments P, I A, or I S ), node i is flipped to state E with probabilities p P , p A, or p S , depending on whether node j is in states P, I A or I S . If, however, the neighbor j is in any of the other states, nothing happens.

Newly infected nodes are transferred to the exposed compartment (E are provided in Supplementary text S1 (Table S3) , the latter, on the other hand, are drawn from lognormal distributions described in Supplementary text S1 (Table S2 ) and weighted for different risk groups according to parameters f Im,i and f H,i described in Supplementary text S1 (Table S3) , respectively.

In parallel, nodes in the susceptible state are being vaccinated with a given vaccination rate p V , whereby a vaccinated individual remains in the susceptible compartment for T V full MCS. Afterward, the nodes switch to the immunity compartment I m with a probability p VA,i , while otherwise, they remain susceptible. Vaccinated individuals who develop immunity remain in the compartment I m for T Im,i full MCS. This immunity period is drawn from a log-normal distribution described in Supplementary text S1 (Table S2) , and the final value is weighted in accordance with the node's health status with parameter f Im,i (see Supplementary text S1, Table S3 ).

We developed an extended SEIRS network model to simulate the dynamics of the SARS-CoV-2 epidemics in a heterogeneous population subjected to infected-dependent restrictions in social interactions and to explore how different vaccination strategies contribute to the confinement of disease progression. In our model, we incorporated the presence of subpopulations with different grades of comorbidities. We integrated different simulation scenarios, where individuals with these systemic diseases were either distributed homogeneously among the population or all located in one district, as presented in Fig. 2 . We investigated the evolution of the epidemics in two types of populations. The first one resembles a younger and healthier society (MHP) with a low fraction of individuals with poor medical conditions, and the second one reflects an older society (LHP) with a relatively high fraction of people with systemic metabolic disturbances and associated comorbidities.

Besides, we considered two strengths of enforced prevention measurements, as defined by Eq. (4).

One strict (Q50) and the other more permissive (Q25). Initially, we focused on simulating the evolution of the COVID-19 epidemic in the heterogeneous network without the introduction of vaccination. The aim was to determine how variability in metabolic health affects the first 9 months of epidemic progression with regard to the structure of the society (homogeneous and segregated) and disease containment strategies (Q25 and Q50). In continuation, the state of the system after 9 months was the initial state for additional simulations, wherein the future epidemic trajectories were studied by incorporating vaccination. Special attention was given to the interplay between vaccination strategies and the heterogeneity of the population.

We 

In what follows, we examine the epidemic trajectories after the population is progressively vaccinated.

We consider two vaccination strategies, i) risky strategy, where individuals in RG3 (first) and RG2

(second) have absolute priority for vaccination, and ii) random strategy, where individuals are vaccinated at random, irrespective of their status. We also consider two vaccination rates, i) 300

individuals/day and ii) 50 individuals/day, which annually amount to 109.5% (full coverage) and 18.25%

(partial coverage) of the population, respectively. The first value roughly mimics the rates that are realized in developed countries, whereas the second represents the rates in less developed countries with a poor supply of vaccines. We introduce vaccination on the 281 st iteration of our simulation, and in each MCS individuals are vaccinated following the selected strategy. Specifically, in each iteration, 300 (or 50) susceptible individuals are selected either entirely at random or at random first from RG3, then from RG2, and finally from RG1, when there are no more susceptible individuals in RG3 and RG2.

By this means, we explore how the distribution of the risk groups in the social network combined with vaccination strategy and the population's overall health affects the mitigation of the disease.

In Fig. 5 we show the progress of the epidemic after the start of vaccination (281 st iteration step) with a vaccination rate of 300 individuals/day in the networks with a homogeneous (Fig. 5A -C) and a segregated ( Fig. 5D-F) for both vaccination strategies (random or priority for risky groups), with a restriction strength set as before (Q25). In Fig. 6 we show the progress of the epidemic after the start of vaccination (281 st iteration step) for either homogeneous (Fig. 6A -C) or segregated (Fig. 6D -F) distribution of risk groups within the social network. It can be seen that if the population is vaccinated at random, the epidemics is progressively suppressed in all scenarios, but much slower when compared to the higher vaccination rate (see Fig. 5 ). Notably, when priority for vaccination is given to individuals from RG3 and RG2, the epidemic is not mitigated. In a society where individuals are distributed homogeneously across the population, the epidemic persists, but the plateau of daily infected is lower than the situation before vaccination. On the other hand, in a segregated society, the daily share of infected individuals even increases. This increase is predominately driven by the increasing numbers of infections among individuals in the RG1 subgroup, who are not vaccinated at all, and, in addition, they progressively lose immunity after the first infection. Furthermore, for the LHP and the homogeneous distribution of individuals within the network, somewhat surprisingly, the cumulative number of deceased individuals keeps rising when priority is given to individuals from risky groups, and the outcome is worse when compared to the random vaccination strategy. Namely, it is not possible to protect all individuals with a low health status at this vaccination rate, and since they interact with individuals from RG1, among which the level of infections is high, they often get infected. Remarkably, in the segregated population structure, the opposite is noticed, as the more vulnerable individuals are, in this case, surrounded mostly by vaccinated individuals within their districts.

To provide a more detailed overview of the results, we plot in the lowermost row of Fig. 6 the change in the total share of infected (Fig. 6G) , hospitalized (Fig. 6H) , and deceased (Fig. 6I ) individuals at the end of simulations (day 700) compared to the starting point of vaccination (day 281). Evidently, if the supply of vaccines is very limited, prioritizing individuals with lower health status leads to higher numbers of infections, as the epidemic cannot be suppressed. Accordingly, the number of hospitalizations is higher as well. However, the impact on mortality rates in this scenario is not trivial.

In the homogeneous MHP, the outcome by either of the vaccination strategies is approximately the same, whereas in the segregated MHP, it is more favorable to vaccinate risky individuals first. This holds true also for the LHP, when the structure of the population is segregated. But if the individuals are distributed homogeneously, giving priority to individuals from RG3 and RG2, turned out to lead to more epidemic deaths. Our simulations have revealed that the demographic structure as well as the spatial arrangement of the population affects the epidemic outcome. It turned out that in the first 280 days of the epidemics without vaccination, there were more infections in the healthier society, even though we have not explicitly considered in our model that healthy and younger individuals are expected to engage in social interactions more often. This would certainly lead to even higher differences in infections, as the social interactions were identified as one of the key parameters affecting the spread of COVID-19 [27, 67] . In contrast, the fractions of hospitalized and deceased individuals were significantly higher in the population with a higher share of individuals with chronic comorbidities and other related diseases, which is a rather expected result. Interestingly, the segregation of chronically ill individuals has led to fewer infections but also to more hospitalizations and deaths when compared to the homogeneous population. Noteworthy, the composition of the society was recognized as even more important after the onset of vaccination, particularly with regards to the vaccination strategy. If priority was given to individuals with lower health status the epidemic persisted and the number of infections in the population was much higher when compared to the random vaccination strategy. If the supply of vaccines was rather high, i.e., 300/day/10 5 , vaccinating less healthy individuals first turned out more favorable, as the number of epidemic deaths was lower, irrespective of the type and structure of the population. If the supply of vaccines is very limited, i.e. 50/day/10 5 , prioritizing individuals with lower health status leads to much higher numbers of infections, as the epidemics cannot be suppressed. In this case, vaccinating first chronically ill individuals leads to significantly more hospitalizations on the population level, whereas the number of casualties in the homogeneous less healthy population is even higher when compared to the random vaccination strategy. However, if individuals with chronic comorbidities are isolated in one district, the prioritizing strategy is much more beneficial. These are important aspects to consider in the design of efficient containment strategies. If the population is well-mixed and the supply of vaccine limited, so that the epidemic cannot be promptly suppressed, it might be more beneficial to vaccinate first individuals, who are more likely to spread the disease, even though they are not directly endangered, but will likely transmit the virus to individuals, who are in risky groups. Because the immune responses in less healthy individuals are more short-lived than in more healthy individuals, it might be more effective to concentrate more on the indirect protection, but for COVID-19 these issues are not yet completely resolved [68] . Nevertheless, if individuals with poor health status are rather isolated, our results indicate that priority should be given to them in either case, as they become protected due to the immunity of individuals within their district. This parallels with findings about influenza, where vaccination was found very beneficial if elderly people are living in communities, such as elderly homes [69] .

In our model, we have included the essential compartments that are commonly employed in models aimed to simulate the spread of the new coronavirus disease and utilized realistic parameter values, where possible. As such, the model allows, in principle for an elementary description and projections of the evolving COVID-19 epidemics. However, we must still be aware that it contains several inherent limitations. First, high variability in country-specific COVID-19 statistics is observed [65] , which can be accounted for by several factors like demography, pool of asymptomatic cases, and the health system structure. Solving this problem of unbiasing data is still an open issue and is particularly important for the development of epidemiological models as well. Second, the spreading of infectious diseases and human behavior are intertwined and is, particularly in the case with the SARS-CoV-2 virus, gradually affected by non-pharmaceutical interventions, which are calling for a coordinated international strategy [70, 71] , as well as by endogenous reductions of social interactions [14, 72, 73] . Our study included this aspect in a very simplified form, i.e., by affecting contact rates by the number of symptomatic infected individuals and hospitalized individuals. This relation is, in reality, much more complicated and can result in diverse epidemic trajectories [73, 74] . Third, while our model accounts for human population heterogeneity, our representation which considers a three-tiered subpopulations scheme with different systemic metabolic disturbances, is very simplified. Not only that in reality, the immunological and health heterogeneity of the population is much more complex and connected with the socio-demographic structure, but also the extent of social engagement depends on the health status of individuals, which is not considered directly in our model [75] . Fourth, in our simulations we have used a rather small and isolated social network with 10 5 nodes, which warrants only a qualitative description of the COVID-19 spread but cannot account for the diverse epidemic patterns observed in different regions around the globe [76] . Fifth, we have considered only two fixed vaccination rates, one high and the other low, which is a simplification of the actual changeable delivery patterns observed in most of the countries. Adjusting an optimal control strategy for vaccine administration with respect to the limited supply in the real world situation is a very complex process [37, 38, 41, 42, 77] , but this is beyond the scope of the present study. Finally, there are, of course, several other aspects to consider when modeling the behavior of spreading dynamics of SARS-CoV-2, such as more complex vaccination strategies, mutations of the virus, how strictly a population is following preventive measures, etc., but currently, the major open issues are the uncertainties of immune periods [78] [79] [80] . While all predictions are, by nature, associated with uncertainty, the reliability of the results depends to a significant extent on the duration of immunity and the probability as well as the nature of reoccurring infections. Given the scarcity of available data, it is impossible to have conclusive evidence about immunity at this stage. However, with time the data on antibody kinetics and biologic features of COVID-19 is rapidly increasing, which will facilitate the development of more accurate models.

Nevertheless, our results clearly highlight that health-related heterogeneity and the spatial social structure crucially affect the evolution of the epidemic as well as the future epidemic trajectories after the onset of vaccination. The risk groups and subpopulations are present in all societies. In the USA, for example, it has been shown that the health disparities in nutrition and obesity correlate closely with the racial and ethnic disparities related to COVID-19 severity and mortality. The age adjusted hospitalization rates for COVID-19 among Native Americans and Black Americans were approximately five and four and a half times that of White Americans, respectively. Also, Latin Americans have been hospitalized at a higher rate. i.e., approximately four times that of White Americans [81] . The proportion of COVID-19 mortality, at least in the studied regions and cities in the USA, such as Chicago and Michigan, was more than twice as high as the proportion of Black residents in their geographic area [81] . For example, looking at specific boroughs, like the Bronx, was characterized by the highest rate of hospitalizations and death related to COVID-19 among all five New York City boroughs [82] .

Strong evidence exists for the link between metabolic health, in particular severe obesity, and the worse in-hospital outcomes, and higher in-hospital mortality, in this borough [83] . The Bronx has indeed considerably higher rates of obesity and chronic diseases due to the disproportionate amount of poverty and food insecurity, as compared with the other boroughs. Obviously, these disparities make the borough's predominantly Black and Latin residents more vulnerable to the devastating effects of COVID-19 [81] . These correlations between the regionally specific populations with worse metabolic health, particularly obesity, and the COVID-19 severity and mortality were also extensively studied in other countries and regions. In a very recent study, using data from 30 industrialized countries, Gardiner et al. [84] show that obesity is the factor most strongly associated with the COVID-19 death rate. Obesity, as a chronic, low-grade systemic inflammation, is a common metabolic disorder that concerns not only COVID-19 severity and mortality, but also the outcome of the vaccination. A major concern is that the COVID-19 vaccines will be less effective for individuals with obesity [31, 85] .

At the moment, we still lack sufficient data to make any conclusions concerning the effectiveness of COVID-19 vaccination in these risk groups. However, less efficient COVID-19 vaccination in people with obesity and other related diseases would be unsurprising, as vaccinations for other diseases, e.g., influenza, hepatitis, and others, have shown that the vaccines are less effective in people with obesity [30, 32, [86] [87] [88] .

All these data show that for a better understanding of the dynamics of virus spread and a better prediction of the outcomes, it is essential that subpopulations at risk for a higher rate of hospitalization and mortality are included in the studies. Computational models are particularly appropriate for such analyses, enabling the recognition of the critical factors for better understanding the epidemic dynamics and contributing to better decision-making processes in societies facing epidemics.

Metabolic health, being particularly emphasized in our study, is not the only disadvantage in the low socio-economic brackets of our society. Influenza-related complications and hospitalization rates [89] have demonstrated that preventative and therapeutic health care, limited sick leave, and household structure might also play a role that needs to be considered.

In conclusion, a combination of the complexity of the transmission processes, limited and uncertain available data, extreme heterogeneity of humans and society, variable large-scale mitigation interventions, and limited supplies of vaccines make it impossible to predict the evolution and consequences of the COVID-19 pandemics. To improve our understanding of the transmission dynamics of this complex disease, a plethora of different kinds of models have recently been developed, each of them aimed to enlighten various aspects on how to optimize the strategies and mitigate the epidemics [11, 26, 34, 57, 90] . Our study proposes a network and agent-based epidemiological model, which offers some advantages compared to standard aggregate S(E)IR-type models, such as the inclusions of complex interaction patterns, locality of social contacts, and spatial heterogeneity of the population. Noteworthy, in our simulations, the latter has proven to be a very important factor affecting the trajectories of COVID-19 epidemics, particularly after the onset of vaccination and when the fraction of individuals with a low health status in the population is relatively high. In future studies, these findings should be further evaluated by more detailed models incorporating realistic spatial demographic data, updated information about the duration of immunity periods, and in the context of various spatiotemporal vaccine distribution strategies.

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

Novel coronavirus 2019-nCoV: Early estimation of epidemiological parameters and epidemic predictions

Effective approach to epidemic containment using link equations in complex networks

Technology to advance infectious disease forecasting for outbreak management

Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures

Sensitivity analysis and optimal control of COVID-19 dynamics based on SEIQR model

Modeling and forecasting of epidemic spreading: The case of Covid-19 and beyond

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A datadriven analysis in the early phase of the outbreak

The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study

The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak

A fractional order SITR mathematical model for forecasting of transmission of COVID-19 of India with lockdown effect

Time, space and social interactions: exit mechanisms for the Covid-19 epidemics

The mathematics of multiple lockdowns

Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy

Infection dynamics of COVID-19 virus under lockdown and reopening

Modelling the spread of COVID-19 with new fractal-fractional operators: Can the lockdown save mankind before vaccination?

Mobility network models of COVID-19 explain inequities and inform reopening

Modeling and prediction of COVID-19 spread in the Philippines by October 13, 2020, by using the VARMAX time series method with preventive measures

Forecasting of COVID-19 cases using deep learning models: Is it reliable and practically significant?

Immunological considerations for COVID-19 vaccine strategies

Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017

Key Guidelines in Developing a Pre-Emptive COVID-19 Vaccination Uptake Promotion Strategy

Power-law population heterogeneity governs epidemic waves

Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years

A mathematical model for the spatiotemporal epidemic spreading of COVID19

A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2

The trinity of COVID-19: immunity, inflammation and intervention

Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study

Impact of obesity on influenza A virus pathogenesis, immune response, and evolution

Obesity and COVID-19: A Perspective from the European Association for the Study of Obesity on Immunological Perturbations, Therapeutic Challenges, and Opportunities in Obesity

Obesity is associated with impaired immune response to influenza vaccination in humans

The Impact of Obesity on Immune Response to Infection and Vaccine: An Insight into Plausible Mechanisms

A primer on using mathematics to understand COVID-19 dynamics: Modeling, analysis and simulations

Will an imperfect vaccine curtail the COVID-19 pandemic in the

A new fractional mathematical modelling of COVID-19 with the availability of vaccine

Determination of an optimal control strategy for vaccine administration in COVID-19 pandemic treatment

Model-informed COVID-19 vaccine prioritization strategies by age and serostatus

A Drive-through Simulation Tool for Mass Vaccination during COVID-19 Pandemic

Identifying communities at risk for COVID-19-related burden across 500 U.S. Cities and within New York City

Strategic spatiotemporal vaccine distribution increases the survival rate in an infectious disease like Covid-19

Optimal governance and implementation of vaccination programs to contain the COVID-19 pandemic

Epidemic outbreaks in complex heterogeneous networks

Superspreading and the effect of individual variation on disease emergence

Spreading dynamics of a SIQRS epidemic model on scale-free networks

Epidemic processes in complex networks

COVID-19 and SARS-CoV-2. Modeling the present, looking at the future

Statistical physics of vaccination

Global dynamics of a network-based SIQRS epidemic model with demographics and vaccination

An agent-based model of dengue virus transmission shows how uncertainty about breakthrough infections influences vaccination impact projections

Simulating phase transitions and control measures for network epidemics caused by infections with presymptomatic, asymptomatic, and symptomatic stages

A network-based explanation of why most COVID-19 infection curves are linear

Network model and analysis of the spread of Covid-19 with social distancing

A social network model of COVID-19

Simulation of the COVID-19 epidemic on the social network of Slovenia: Estimating the intrinsic forecast uncertainty

A data-driven network model for the emerging COVID-19 epidemics in Wuhan, Toronto and Italy

Using a real-world network to model localized COVID-19 control strategies

Emergence of soft communities from geometric preferential attachment

Sustaining the Internet with hyperbolic mapping

Public goods games on random hyperbolic graphs with mixing

Metric clusters in evolutionary games on scale-free networks

Endogenous social distancing and its underappreciated impact on the epidemic curve

Community lockdowns in social networks hardly mitigate epidemic spreading

Popularity versus similarity in growing networks

Robust estimation of diagnostic rate and real incidence of COVID-19 for European policymakers

The SEIRS model for infectious disease dynamics

Stages of COVID-19 pandemic and paths to herd immunity by vaccination: dynamical model comparing Austria, Luxembourg and Sweden

Understanding COVID-19 vaccine efficacy

The Efficacy and Cost Effectiveness of Vaccination against Influenza among Elderly Persons Living in the Community

An action plan for pan-European defence against new SARS-CoV-2 variants

Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections

Non-pharmaceutical interventions during the COVID-19 pandemic: A review

Adaptive social contact rates induce complex dynamics during epidemics

Tracking the early depleting transmission dynamics of COVID-19 with a time-varying SIR model

Age-stratified discrete compartment model of the COVID-19 epidemic with application to Switzerland

The COVID-19 pandemic: Diverse contexts; Different epidemics -How and why?

The Joint Impact of COVID-19 Vaccination and Non-Pharmaceutical Interventions on Infections, Hospitalizations, and Mortality: An Agent-Based Simulation

SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients

Covid-19 and Disparities in Nutrition and Obesity

Variation in COVID-19 Hospitalizations and Deaths Across New York City Boroughs

Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx

Obesity as a driver of international differences in COVID-19 death rates

Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships

The Impact of Obesity on Immune Response to Infection and Vaccine: An Insight into Plausible Mechanisms

Impact of Body Mass Index on Immunogenicity of Pandemic H1N1 Vaccine in Children and Adults

Obesity-Induced Changes in T-Cell Metabolism Are Associated With Impaired Memory T-Cell Response to Influenza and Are Not Reversed With Weight Loss

Socio-economic bias in influenza surveillance

An agent-based model to evaluate the COVID-19 transmission risks in facilities

We gratefully acknowledge funding from the Slovenian Research Agency (Grant Nos. P1-0403, J1-2457, P3-0396, P1-0055, and I0-0029).